Evidence map›Paper›PMID 39179421›Full record

ArticlePlant physiology2024

A cyclical marker system enables indefinite series of oligonucleotide-directed gene editing in Chlamydomonas reinhardtii.

Ian L Ross, Hong Phuong Le, Sabar Budiman, Dake Xiong, Fritz Hemker, Elizabeth A Millen, Melanie Oey, Ben Hankamer

Abstract read
In one paragraph

Article in Plant physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Gene Editing inBio-protocol · 2026
    Article
  2. Article
  3. CRISPR-Cas Technology TurnsMarine drugs · 2025
    Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ian L RossInstitute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, QLD 4072, Australia.ORCID 0000-0002-2389-4292
Hong Phuong LeInstitute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, QLD 4072, Australia.ORCID 0000-0002-2862-6502
Sabar BudimanInstitute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, QLD 4072, Australia.ORCID 0000-0001-6619-8396
Dake XiongInstitute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, QLD 4072, Australia.ORCID 0000-0003-4089-3715
Fritz HemkerInstitute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, QLD 4072, Australia.
Elizabeth A MillenInstitute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, QLD 4072, Australia.
Melanie OeyInstitute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, QLD 4072, Australia.ORCID 0000-0001-9290-0580
Ben HankamerInstitute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, QLD 4072, Australia.

Funding

Australian Research Council LP170100717Can Tho UniversityNational Health and Medical Research Council GNT1176216University of Queensland
6 · The paper itself

Abstract

CRISPR/Cas9 gene editing in the model green alga Chlamydomonas reinhardtii relies on the use of selective marker genes to enrich for nonselectable target mutations. This becomes challenging when many sequential modifications are required in a single-cell line, as useful markers are limited. Here, we demonstrate a cyclical selection process which only requires a single marker gene to identify an almost infinite sequential series of CRISPR-based target gene modifications. We used the NIA1 (Nit1, NR; nitrate reductase) gene as the selectable marker in this study. In the forward stage of the cycle, a stop codon was engineered into the NIA1 gene at the CRISPR target location. Cells retaining the wild-type NIA1 gene were killed by chlorate, while NIA1 knockout mutants survived. In the reverse phase of the cycle, the stop codon engineered into the NIA1 gene during the forward phase was edited back to the wild-type sequence. Using nitrate as the sole nitrogen source, only the reverted wild-type cells survived. By using CRISPR to specifically deactivate and reactivate the NIA1 gene, a marker system was established that flipped back and forth between chlorate- and auxotrophic (nitrate)-based selection. This provided a scarless cyclical marker system that enabled an indefinite series of CRISPR edits in other, nonselectable genes. We demonstrate that this "Sequential CRISPR via Recycling Endogenous Auxotrophic Markers (SCREAM)" technology enables an essentially limitless series of genetic modifications to be introduced into a single-cell lineage of C. reinhardtii in a fast and efficient manner to complete complex genetic engineering.

Indexed as

Chlamydomonas reinhardtiiCRISPR-Cas SystemsGene EditingGenetic MarkersNitrate ReductaseOligonucleotidesGenetic MarkersNitrate ReductaseOligonucleotides

Identifiers

PMID39179421
PMCPMC11637769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.